$GEN Income Statement | Understand Stock

$GEN

$24.25 -$0.16 (0.66%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Apr 3, 2026	FY2025 12 months to Mar 28, 2025	FY2024 12 months to Mar 29, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Apr 1, 2022
Net revenues
Cost of revenues
Gross profit
Operating expenses:
Sales and marketing
Research and development
General and administrative
Amortization of intangible assets
Restructuring and other costs
Impairment of intangible assets
Total operating expenses
Operating income (loss)
Interest expense
Other income (expense), net
Income (loss) before income taxes
Income tax expense (benefit)
Income (loss) from continuing operations
Income (loss) from discontinued operations
Net income (loss)
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Net income (loss) per share - basic (in dollars per share)
Net income (loss) per share - diluted (in dollars per share)
Weighted-average shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments